SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Santos Sanz Sara)
 

Sökning: WFRF:(Santos Sanz Sara) > Mycoplasma pneumoni...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00008006naa a2200889 4500
001oai:DiVA.org:uu-406063
003SwePub
008200304s2020 | |||||||||||000 ||eng|
009oai:prod.swepub.kib.ki.se:142763266
0247 a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-4060632 URI
0247 a https://doi.org/10.2807/1560-7917.ES.2020.25.2.19001122 DOI
0247 a http://kipublications.ki.se/Default.aspx?queryparsed=id:1427632662 URI
040 a (SwePub)uud (SwePub)ki
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
1001 a Beeton, Michael L.u Cardiff Metropolitan Univ, Dept Biomed Sci, Cardiff, S Glam, Wales4 aut
2451 0a Mycoplasma pneumoniae infections, 11 countries in Europe and Israel, 2011 to 2016
264 1b EUR CENTRE DIS PREVENTION & CONTROL,c 2020
338 a electronic2 rdacarrier
520 a Background: Mycoplasma pneumoniae is a leading cause of community-acquired pneumonia, with large epidemics previously described to occur every 4 to 7 years.Aim: To better understand the diagnostic methods used to detect M. pneumoniae; to better understand M. pneumoniae testing and surveillance in use; to identify epidemics; to determine detection number per age group, age demographics for positive detections, concurrence of epidemics and annual peaks across geographical areas; and to determine the effect of geographical location on the timing of epidemics.Methods: A questionnaire was sent in May 2016 to Mycoplasma experts with national or regional responsibility within the ESCMID Study Group for Mycoplasma and Chlamydia Infections in 17 countries across Europe and Israel, retrospectively requesting details on M. pneumoniae-positive samples from January 2011 to April 2016. The Moving Epidemic Method was used to determine epidemic periods and effect of country latitude across the countries for the five periods under investigation.Results: Representatives from 12 countries provided data on M. pneumoniae infections, accounting for 95,666 positive samples. Two laboratories initiated routine macrolide resistance testing since 2013. Between 2011 and 2016, three epidemics were identified: 2011/12, 2014/15 and 2015/16. The distribution of patient ages for M. pneumoniae-positive samples showed three patterns. During epidemic years, an association between country latitude and calendar week when epidemic periods began was noted.Conclusions: An association between epidemics and latitude was observed. Differences were noted in the age distribution of positive cases and detection methods used and practice. A lack of macrolide resistance monitoring was noted.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Infektionsmedicin0 (SwePub)302092 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Infectious Medicine0 (SwePub)302092 hsv//eng
7001 a Zhang, Xu-Shengu Publ Hlth England, London, England4 aut
7001 a Uldum, Soren A.u Statens Serum Inst, Dept Bacteria Parasites & Fungi, Copenhagen, Denmark4 aut
7001 a Bebear, Cecileu Univ Bordeaux, Mycoplasmal & Chlamydia Infect Humans, USC EA 3671, Bordeaux, France4 aut
7001 a Dumke, Rogeru Tech Univ Dresden, Dresden, Germany4 aut
7001 a Gullsby, Karolinau Uppsala universitet,Centrum för klinisk forskning, Gävleborg4 aut0 (Swepub:uu)kagul102
7001 a Ieven, Margaretau Antwerp Univ Hosp Edegem, Edegem, Belgium4 aut
7001 a Loens, Katherineu Antwerp Univ Hosp Edegem, Edegem, Belgium4 aut
7001 a Nir-Paz, Ranu Hadassah Hebrew Univ, Med Ctr, Dept Clin Microbiol & Infect Dis, Jerusalem, Israel4 aut
7001 a Pereyre, Sabineu Univ Bordeaux, Mycoplasmal & Chlamydia Infect Humans, USC EA 3671, Bordeaux, France4 aut
7001 a Spiller, O. Bradu Cardiff Univ, Sch Med, Dept Med Microbiol, Div Infect & Immun, Cardiff, S Glam, Wales4 aut
7001 a Chalker, Victoria J.u Publ Hlth England, London, England4 aut
7001 a Bossuyt, Nathalieu Sciensano, Serv Epidemiol Infect Dis, Brussels, Belgium4 aut
7001 a Lagrou, Katrienu Univ Hosp Leuven, Natl Reference Ctr Resp Pathogens, Leuven, Belgium4 aut
7001 a Mitis, Georgeu Nicosia Gen Hosp, Dept Immunol, Nicosia, Cyprus4 aut
7001 a Koliou, Mariau Archbishop Makarios III Hosp, Dept Paediat, Nicosia, Cyprus4 aut
7001 a Havlickova, Martinau Natl Inst Publ Hlth, Prague, Czech Republic4 aut
7001 a Kyncl, Janu Natl Inst Publ Hlth, Prague, Czech Republic4 aut
7001 a Emborg, Hanne-Dortheu Statens Serum Inst, Copenhagen, Denmark4 aut
7001 a Voldstedlund, Marianneu Statens Serum Inst, Copenhagen, Denmark4 aut
7001 a MacKenzie, Colin Raeu Heinrich Heine Univ, Inst Med Microbiol & Hosp Hyg, Dusseldorf, Germany4 aut
7001 a Maltezou, Helena C.u Natl Publ Hlth Org, Athens, Greece4 aut
7001 a Georgakopoulou, Theanou Natl Publ Hlth Org, Athens, Greece4 aut
7001 a Petridou, Evangelinau Aghia Sophia Children Hosp, Athens, Greece4 aut
7001 a Banou, Kirkirau Aghia Sophia Children Hosp, Athens, Greece4 aut
7001 a Balla, Eszteru Natl Publ Hlth Ctr, Dept Reference Labs, Budapest, Hungary4 aut
7001 a Connell, Jeffu Univ Coll Dublin, Natl Virus Reference Lab, Dublin, Ireland4 aut
7001 a Yandle, Zoeu Univ Coll Dublin, Natl Virus Reference Lab, Dublin, Ireland4 aut
7001 a Moran, Joanneu Univ Coll Dublin, Natl Virus Reference Lab, Dublin, Ireland4 aut
7001 a Burns, Karenu Hlth Protect Surveillance Ctr, Dublin, Ireland4 aut
7001 a Michael-Gayego, Ayeletu Hadassah Hebrew Univ, Med Ctr, Dept Clin Microbiol & Infect Dis, Jerusalem, Israel4 aut
7001 a Moses, Allon E.u Hadassah Hebrew Univ, Med Ctr, Dept Clin Microbiol & Infect Dis, Jerusalem, Israel4 aut
7001 a Fenech, Tanya Melillou Minist Hlth, Valletta, Malta4 aut
7001 a Anestad, Gabrielu Norwegian Inst Publ Hlth, Oslo, Norway4 aut
7001 a Blystad, Hansu Norwegian Inst Publ Hlth, Oslo, Norway4 aut
7001 a Vestrheim, Didrik F.u Norwegian Inst Publ Hlth, Oslo, Norway4 aut
7001 a Froes, Filipeu Hosp Pulido Valente, Lisbon, Portugal;Gen Directorate Hlth Consultant Pneumol, Lisbon, Portugal4 aut
7001 a Kese, Darjau Univ Ljubljana, Fac Med, Ljubljana, Slovenia;Inst Microbiol & Immunol, Ljubljana, Slovenia4 aut
7001 a Socan, Majau Natl Inst Publ Hlth, Ljubljana, Slovenia4 aut
7001 a Cano Portero, Rosau Inst Salud Carlos III, CIBERESP, Natl Ctr Epidemiol, Madrid, Spain4 aut
7001 a Santos Sanz, Sarau Minist Hlth Social Affairs & Equal, Directorate Gen Publ Hlth, Coordinat Alerts & Publ Hlth Emergencies, Madrid, Spain4 aut
7001 a Suarez Rodriguez, Bertau Minist Hlth Social Affairs & Equal, Directorate Gen Publ Hlth, Coordinat Alerts & Publ Hlth Emergencies, Madrid, Spain4 aut
7001 a Ternhag, Andersu Karolinska Institutet4 aut
7001 a Giske, Christianu Karolinska Institutet4 aut
7001 a Wisell, Karin Tegmarku Publ Hlth Agcy Sweden, Stockholm, Sweden4 aut
7001 a Marques, Diogo Pereirau Hlth Protect Scotland, Glasgow, Lanark, Scotland4 aut
7001 a Reynolds, Arleneu Hlth Protect Scotland, Glasgow, Lanark, Scotland4 aut
7001 a McMenamin, Jimu Hlth Protect Scotland, Glasgow, Lanark, Scotland4 aut
7102 a Cardiff Metropolitan Univ, Dept Biomed Sci, Cardiff, S Glam, Walesb Publ Hlth England, London, England4 org
7730 t Eurosurveillanced : EUR CENTRE DIS PREVENTION & CONTROLg 25:2, s. 39-51q 25:2<39-51x 1025-496Xx 1560-7917
8564 u https://uu.diva-portal.org/smash/get/diva2:1411862/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-406063
8564 8u https://doi.org/10.2807/1560-7917.ES.2020.25.2.1900112
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:142763266

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy